Rigenerand

Rigenerand

Develops and manufactures cGMP-grade systems and products for cell- and gene-therapy applications using 3D culture and clean-room facilities.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor

€0.0

round
*

N/A

Acquisition
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2018201920202021202220232024
Revenues0000000000000000000000000000
% growth-(58 %)412 %362 %1628 %126 %25 %
EBITDA0000000000000000000000000000
% EBITDA margin(3770 %)(12958 %)(5217 %)(969 %)---
Profit0000000000000000000000000000
% profit margin(5205 %)(19839 %)(7813 %)(1655 %)(213 %)23 %3 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article

Notes (0)
More about Rigenerand
Made with AI
Edit

Rigenerand operates in the advanced medicine sector, focusing on the development and production of cGMP (current Good Manufacturing Practice) products for cell and gene therapy. The company also specializes in creating tailored 3D culture biomedical devices used for both diagnostic and therapeutic applications. Rigenerand serves clients in the pharmaceutical and biotechnology industries, providing solutions that enhance drug testing, gene therapy, and immuno-oncology research. The company’s business model revolves around the sale of its proprietary products and services, which are designed to meet stringent regulatory standards and improve patient outcomes. Rigenerand generates revenue through the commercialization of its innovative 3D bioreactor systems and extracellular vesicle exosomes, which are essential for advanced therapeutic applications. The company is ISO 9001:2015 certified by TUV SUD, ensuring high-quality standards in its operations.

Keywords: cGMP, cell therapy, gene therapy, 3D culture, biomedical devices, diagnostics, therapeutics, bioreactor, exosomes, immuno-oncology.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo